Source: Frontiers in Immunology. Unidade: FCF
Subjects: VACINAS, BACTÉRIAS PATOGÊNICAS
ABNT
CORIA, Lorena Mirta et al. Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. Frontiers in Immunology, v. 16, p. 1-16 art. 1679540, 2025Tradução . . Disponível em: https://dx.doi.org/10.3389/fimmu.2025.1679540. Acesso em: 30 jan. 2026.APA
Coria, L. M., Castro, C. P., Bruno, L., Nakaya, H. T. I., Pasquevich, K. A., & Cassataro, J. (2025). Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. Frontiers in Immunology, 16, 1-16 art. 1679540. doi:10.3389/fimmu.2025.1679540NLM
Coria LM, Castro CP, Bruno L, Nakaya HTI, Pasquevich KA, Cassataro J. Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations [Internet]. Frontiers in Immunology. 2025 ; 16 1-16 art. 1679540.[citado 2026 jan. 30 ] Available from: https://dx.doi.org/10.3389/fimmu.2025.1679540Vancouver
Coria LM, Castro CP, Bruno L, Nakaya HTI, Pasquevich KA, Cassataro J. Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations [Internet]. Frontiers in Immunology. 2025 ; 16 1-16 art. 1679540.[citado 2026 jan. 30 ] Available from: https://dx.doi.org/10.3389/fimmu.2025.1679540

